TABLE 4

Secondary endpointsa

CharacteristicUnmatched cohortMatched cohort
VAN-TZP (n = 3,605)VAN-FEP (n = 588)P valueVAN-TZP (n = 1,633)VAN-FEP (n = 578)P value
Median (IQR) time (days) to AKI5 (3–9)8 (4–16.8)0.00065 (3–9)8 (4–17)0.0004
Median (IQR) hospital length of stay (days)8 (4–15)8 (4–17)0.088 (4–15)8 (5–17)0.9
No. (%) of patients with in-hospital mortality276 (7.7)53 (9.0)0.3113 (6.9)53 (9.2)0.09
  • a FEP, cefepime; IQR, interquartile range; TZP, piperacillin-tazobactam; VAN, vancomycin.